Mayo Clinic Proceedings Home


        Incorrect name of institution: In the article by Agarwal entitled “Effects of Statins on Renal Function,” published in the November 2007 issue of Mayo Clinic Proceedings (Mayo Clin Proc. 2007;82(11): 1381-1390), the name of Dr Agarwal's institution was printed incorrectly. It should read as follows: Richard L. Roudebush VA Medical Center, Indianapolis, IN.

        Linked Article

        • Effects of Statins on Renal Function
          Mayo Clinic ProceedingsVol. 82Issue 11
          • Preview
            Patients with chronic kidney disease (CKD) are much more likely to die of cardiovascular disease than end-stage renal disease. Dyslipidemia is highly prevalent in patients with CKD and may contribute to the elevated cardiovascular risk as well as CKD progression. Statins are lipid-lowering drugs that appear to protect the kidneys via cholesterol reduction as well as noncholesterol-mediated mechanisms. Subgroup analyses of major clinical studies and meta-analyses of smaller trials indicate that statin therapy slows the decline of the glomerular filtration rate.
          • Full-Text
          • PDF